MAIA Biotechnology Inc (AMEX: MAIA)’s stock price has gone rise by 16.40 in comparison to its previous close of 1.89, however, the company has experienced a 18.28% increase in its stock price over the last five trading days. businesswire.com reported 2025-02-04 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer.
Is It Worth Investing in MAIA Biotechnology Inc (AMEX: MAIA) Right Now?
Moreover, the 36-month beta value for MAIA is 0.21. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MAIA is 21.06M and currently, short sellers hold a 3.02% of that float. On February 04, 2025, MAIA’s average trading volume was 257.25K shares.
MAIA’s Market Performance
MAIA stock saw an increase of 18.28% in the past week, with a monthly gain of 5.26% and a quarterly increase of -20.86%. The volatility ratio for the week is 4.41%, and the volatility levels for the last 30 days are 8.30% for MAIA Biotechnology Inc (MAIA). The simple moving average for the last 20 days is 8.72% for MAIA’s stock, with a simple moving average of -22.32% for the last 200 days.
MAIA Trading at 6.54% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.27% of loss for the given period.
Volatility was left at 8.30%, however, over the last 30 days, the volatility rate increased by 4.41%, as shares sank -0.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.91% upper at present.
During the last 5 trading sessions, MAIA rose by +18.82%, which changed the moving average for the period of 200-days by +11.62% in comparison to the 20-day moving average, which settled at $2.0240. In addition, MAIA Biotechnology Inc saw 11.11% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Smith Stan, who purchase 25,000 shares at the price of $1.87 back on Dec 13 ’24. After this action, Smith Stan now owns 1,130,060 shares of MAIA Biotechnology Inc, valued at $46,800 using the latest closing price.
Guerrero Ramiro, the Director of MAIA Biotechnology Inc, purchase 53,418 shares at $1.87 during a trade that took place back on Dec 13 ’24, which means that Guerrero Ramiro is holding 514,970 shares at $99,998 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -3.26. Equity return is now at value -1188.16, with -319.37 for asset returns.
Currently, EBITDA for the company is -20.18 million with net debt to EBITDA at 0.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.56.
Conclusion
To wrap up, the performance of MAIA Biotechnology Inc (MAIA) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
